Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-01
2011-11-08
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S315000, C514S398000, C514S426000, C514S447000, C514S472000, C514S623000, C544S164000, C548S331100, C548S326500, C548S579000, C548S543000, C549S480000, C549S069000
Reexamination Certificate
active
08053435
ABSTRACT:
The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacetylase, leading effective suppression of cancer cell proliferation.
REFERENCES:
patent: 2007-0047024 (2007-05-01), None
patent: 2003/076395 (2003-09-01), None
patent: 2004/063146 (2004-07-01), None
patent: 2004/065354 (2004-08-01), None
patent: 2004/076386 (2004-09-01), None
patent: 2007/052938 (2007-05-01), None
Cho Joong Myung
Hyun Young Lan
Jeong Won Jang
Jung Hee Jung
Kim Jae Hak
Barker Michael
Chu Yong
Crystalgenomics, Inc.
Korea Research Institute of Chemical Technology
Lucas & Mercanti LLP
LandOfFree
Naphthalenyloxypropenyl derivatives having inhibitory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthalenyloxypropenyl derivatives having inhibitory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalenyloxypropenyl derivatives having inhibitory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4277004